Neumora Therapeutics, Inc. Common Stock
USD1.61
-0.01 (-0.92%)
CEO
Paul L. Berns
IPO Date
2023-09-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.64
Prev. Close
$1.63
Day Low
$1.59
Day High
$1.67
52W Low
$0.83
52W High
$3.65
Market Cap
$0.30B
Volume
0.40M
| 80,000 |
| $1.86 |
| 29 May 2026 | Piacquad David | director | A-Award | Acquired | 80,000 | $1.86 |
| 29 May 2026 | Halawa Alaa | director | A-Award | Acquired | 80,000 | $1.86 |
| 29 May 2026 | Ho Maykin | director | A-Award | Acquired | 80,000 | $1.86 |
| 19 Feb 2026 | Aurora Daljit Singh | See Remarks | S-Sale | Disposed | 6,165 | $3.56 |
| 19 Feb 2026 | Pinto Joshua | President | S-Sale | Disposed | 5,967 | $3.54 |
| 19 Feb 2026 | BERNS PAUL L | director, officer: See Remarks | S-Sale | Disposed | 9,819 | $3.51 |
| 19 Feb 2026 | Milligan Michael Lee | See Remarks | S-Sale | Disposed | 1,436 | $3.56 |
| 9 Jan 2026 | Milligan Michael Lee | See Remarks | A-Award | Acquired | 350,000 | $2.33 |